News
C4X Discovery - Interim results
RNS Number: 6492 K C4X Discovery Holdings PLC 12 April 2018 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/ 596/ EU.. ·On 29 March 2018, post-period end, C4XD announced a licensing deal with Indivior worth up to $294 million for C4XD's oral Orexin-1 receptor antagonist for the treatment of addiction, receiving $10...
RNS Number: 6492 K C4X Discovery Holdings PLC 12 April 2018 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/ 596/ EU.. ·On 29 March 2018, post-period end, C4XD announced a licensing deal with Indivior worth up to $294 million for C4XD's oral Orexin-1 receptor antagonist for the treatment of addiction, receiving $10...